New Cardiovascular Horizons (NCVH) 2017

 

New Cardiovascular Horizons (NCVH) 2017
Avatar

Boston Scientific Global DE Clinical Program

By New Cardiovascular Horizons (NCVH) 2017 FEATURING Fadi Saab
By New Cardiovascular Horizons (NCVH) 2017 FEATURING Fadi Saab
7 views
September 15, 2017
Comments 0
Login to view comments. Click here to Login
[The Business of Peripheral Interventions] Session III
13:40

Drug-Eluting Balloons: A New Era in SFA Treatment

New Cardiovascular Horizons (NCVH) 2017

H. Ahmed

376 views
14:17

In-Stent Restenosis is a Nightmare: How Can We Treat It?

New Cardiovascular Horizons (NCVH) 2017

E. Dippel

8 views
14:27

Drug-Eluting Stents in Treating Peripheral Vascular Disease

New Cardiovascular Horizons (NCVH) 2017

O. Ibrahim

38 views
13:52

CO2 Angiography: Its Role in Medicine

New Cardiovascular Horizons (NCVH) 2017

J. Caridi

6 views
12:34

Ultrasound for Diagnosis, Access and Treatment of Peripheral Arteria…

New Cardiovascular Horizons (NCVH) 2017

25 views
11:19

DEFINITIVE LE: What Have We Learned with the Largest Atherectomy Reg…

New Cardiovascular Horizons (NCVH) 2017

12 views
15:48

The Importance of True Comparative Studies of Peripheral Vascular Di…

New Cardiovascular Horizons (NCVH) 2017

12 views
15:09

Boston Scientific Global DE Clinical Program

New Cardiovascular Horizons (NCVH) 2017

F. Saab

7 views